Arnon P. Kater, Yanwen Jiang, Brenda Chyla, and John F. Seymour. 2020. “Response in Patients With BIRC3-Mutated relapsed/Refractory Chronic Lymphocytic Leukemia Treated With Fixed-Duration Venetoclax and Rituximab”. Haematologica 105 (7). Pavia, Italy, e382-e383. https://doi.org/10.3324/haematol.2020.253849.